Federated Hermes MDT Small Cap Growth distinguishes itself with a machine-learning-driven quantitative process designed to tap multiple, evolving sources of alpha. Its Above Average Process rating reflects confidence in the strategy’s ability to effectively combine valuation, quality, and technical signals within a single, flexible framework. Its People rating remains Average. This strategy includes mutual fund and separately managed account vehicles.
Federated Hermes MDT Small Cap Growth Fund Class C Shares QCSGX
- NAV / 1-Day Return 25.75 / +0.90 %
- Total Assets 823.7M
-
Adj. Expense Ratio
2.020%
- Expense Ratio 1.960%
- Distribution Fee Level Above Average
- Share Class Type Level Load
- Category Small Growth
- Investment Style Small Growth
- Min. Initial Investment 1,500
- Status Open
- TTM Yield 0.00
- Turnover 91%
USD | NAV as of Oct 03, 2026 | 1-Day Return as of Oct 03, 2026, 12:11 AM GMT+0
Morningstar’s Analysis QCSGX
Will QCSGX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 15.1
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Federated Govt Oblg Pr Shares | 2.91 | 25M | — |
BrightSpring Health Services Inc | 1.89 | 16M | Healthcare |
Arteris Inc | 1.66 | 14M | Technology |
Liquidia Corp Ordinary Shares | 1.54 | 13M | Healthcare |
Indivior Pharmaceuticals Inc Ordinary Share | 1.34 | 11M | Healthcare |
American Healthcare REIT Inc Ordinary Shares | 1.24 | 10M | Real Estate |
Axsome Therapeutics Inc | 1.18 | 10M | Healthcare |
Acadian Asset Management Inc | 1.13 | 10M | Financial Services |
SPS Commerce Inc | 1.13 | 10M | Technology |
Mirum Pharmaceuticals Inc | 1.10 | 9M | Healthcare |